Player FM - Internet Radio Done Right
Checked 3d ago
Aggiunto tre anni fa
Contenuto fornito da Clinical Research News. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Clinical Research News o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !
Vai offline con l'app Player FM !
Podcast che vale la pena ascoltare
SPONSORIZZATO
Matt Deseno is the founder of multiple award winning marketing businesses ranging from a attraction marketing to AI appointment setting to customer user experience. When he’s not working on the businesses he teaches marketing at Pepperdine University and he also teaches other marketing agency owners how they created a software company to triple the profitability for the agency. Our Sponsors: * Check out Kinsta: https://kinsta.com * Check out Mint Mobile: https://mintmobile.com/tmf * Check out Moorings: https://moorings.com * Check out Trust & Will: https://trustandwill.com/TRAVIS * Check out Warby Parker: https://warbyparker.com/travis Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy…
The Scope of Things
Segna tutti come (non) riprodotti ...
Manage series 3335332
Contenuto fornito da Clinical Research News. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Clinical Research News o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior Writer welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.
…
continue reading
36 episodi
Segna tutti come (non) riprodotti ...
Manage series 3335332
Contenuto fornito da Clinical Research News. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Clinical Research News o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior Writer welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.
…
continue reading
36 episodi
すべてのエピソード
×![Artwork](/static/images/128pixel.png)
1 Episode: 35 - SCOPE 2025, Participant Engagement Award Winners, How AI is Helping Trials, and More 23:44
In this episode of the Scope of Things, host Deborah Borfitz provides the latest on new criteria for defining and diagnosing obesity, the case for including pregnant women in vaccine trials, the subtyping of osteosarcoma, an inert gas being tested as an Alzheimer’s treatment, and more. Joining the conversation is David Sall, president and CEO of Patient Enrollment Advisors, who talks about the origins of the Participant Engagement Award at SCOPE 2025 and how the conversation around participant engagement has changed over time (and the changes that still need to happen). Finally, we have Allison Proffitt, editorial director of Clinical Research News , interviewing Trân Lê and Sohit Gatiganti, co-founders of Grove AI and the winners of the Participant Engagement Award at SCOPE 2025. The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.…
![Artwork](/static/images/128pixel.png)
1 Episode: 34 - Ringing in 2025 With Validating Novel Digital Clinical Measures, Decentralized Trials, and More 27:13
In this episode of the Scope of Things, host Deborah Borfitz delivers the news on an investigation into data reporting problems in major Ticagrelor clinical trial PLATO, the need for more sex-aware cancer research, Alzheimer’s studies looking at brain shrinkage associated with immunotherapies (and repurposing drugs as potential new treatments), and a large, decentralized trial that successfully uncovered disease-causing genetic variants in hundreds of participants. Benjamin Vandendriessche, chief delivery officer of Digital Medicine Society, also joins in to talk about a newly completed project with the FDA that is providing guidance and resources on how to validate novel digital clinical measures. News Roundup PLATO trial investigation Findings published in The BMJ “OncoSexome” project Paper in Nucleic Acids Research Brain shrinkage with Alzheimer’s treatment Research in The Lancet Neurology Repurposing drugs for Alzheimer’s Study in Alzheimer’s & Dementia Mayo Clinic Tapestry study Article in Mayo Clinic Proceedings Guest Benjamin Vandendriessche, chief delivery officer, Digital Medicine Society The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.…
![Artwork](/static/images/128pixel.png)
1 Episode:33 - Orr Inbar Discusses Saving Costs and Complications With Clinical Trial Simulations 34:33
In this episode of the Scope of Things, host Deborah Borfitz covers concerns surrounding the study and treatment of obesity, a new “opening doors” initiative to clinical trials, debate over the European Union AI Act, the first international-level clinical study using secure multiparty computation, a hopeful treatment for kids with lethal brain tumors, and a ChatGPT tool created by the NIH to match potential volunteers to relevant studies. Joining the conversation is Orr Inbar, CEO and co-founder of QuantHealth, who discusses how his company is using AI to simulate clinical trials to alleviate costs and efficiency issues for the notoriously complicated drug development process. He also shares the proprietary tech powering QuantHealth’s AI and where he sees AI heading as 2025 unfolds. News Roundup Perspectives on the EU AI Act Insights about the rollout in Clinical Research News Article in Clinical Research News about discussion at SCOPE Europe Secure multiparty computation Article in Bio-IT World Study in npj Digital Medicine Cell therapy for childhood brain cancer Study published in Nature Stanford Medicine press release TrialGPT tool Study in Nature Communications The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.…
In this episode of the Scope of Things, host Deborah Borfitz shares the latest news on a drug repurposing AI model now being tested in rare disease clinical trials, a new way forward for triple-negative breast cancer, Jill Pellegrino’s transition from CVS to AutoCruitment, incorporating placental pathology into perspective clinical trials, making ethical oversight of clinical trials more “fit-for-purpose,” and publication bias with industry sponsored studies for psychiatric drugs. We also have Allison Proffitt, editorial director of Clinical Research News , interviewing speakers at SCOPE Europe 2024 on how AI is being used for clinical trials, their pick for the 2024 rising star in the clinical research ecosystem, and the most hotly-debated topics in trial planning and execution. SHOW NOTES News Roundup AI for drug repurposing Study in Nature Medicine Window trial for new breast cancer approach Study in Science Advances Article in Bio-IT World Prescreening regimen of AutoCruitment Article in Clinical Research News Episode 12 guest appearance on podcast Trials needing placental pathology Opinion piece in Trends in Molecular Medicine Fit-for-purpose ethical oversight Special communication in JAMA “Sponsorship effect” on psychiatric drug trials Study in Journal of Political Economy Guests Nicole Stansbury, Head of Global Clinical Operations at Premier Research Farrell Healion, Head of Emerging Technologies at AstraZeneca Jonathan Crowther, Head of Predictive Analytics, PRD (OARS), Pfizer The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.…
Tune in for the latest news and trends in this month’s episode of the Scope of Things, where host Deborah Borfitz covers everything you need to know about a pending launch of a large treatment trial for Graves’ disease, a recruitment campaign for a diagnostic tampon, Walgreens and BARDA’s new partnership, how eligibility criteria has been excluding people of African or Middle Eastern descent from cancer studies, and more. Joining the discussion is Aaron Mackey, vice president of AI and data science at Lokavant, who talks about the unintended consequences of decisions made during trial planning that can lead to questionable conclusions, how AI and ML are helping with the diversity issue in trial participation, and his stop gap emergency plan to keep trials on track if there is no digital support available. SHOW NOTES News Roundup Phase 3 trial for Graves’ disease Article in Clinical Research News Quality of life measures in cancer studies Study in Journal of Clinical Oncology Article in Clinical Research News Rapid recruitment for a diagnostic tampon trial Article in Clinical Research News Reference trial emulation Study in PLOS Medicine Walgreens/BARDA partnership News brief in Clinical Research News “Detective” algorithm for improving trial design Study in Nature Genetics Exclusion of people with Duffy-null phenotype Study in JAMA Network Open The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.…
This month’s episode of The Scope of Things features the latest trending news from host Deborah Borfitz, including a planned library of “nature’s drugs” targeting complex diseases, a paradoxical approach to treating cancer, how government policies can help improve equitable access to cancer trials, and the possibilities of reversing multiple sclerosis nerve damage. Marshall Summar, CEO of Uncommon Cures, and Tamanna Roshan Lal, Chief Medical Officer of Uncommon Cures, join the conversation to discuss how their organization is tackling the root causes of rare diseases trials that take too long and cost too much. They delve into the market interest behind rare disease trials and what Uncommon Cures is doing differently, as well as share the company’s international expansion plans and where they see this operationalized rare disease clinical trial paradigm in a few years. SHOW NOTES News Roundup Pharmaceutical-grade HMOs Article in Clinical Research News Paradoxical cancer treatment approach Study in Cancer Discovery Article in Clinical Research News Switching on the desire the exercise Study in Science Advances STEP stroke platform trial Press release from the University of Cincinnati Policy interventions to improve trial equity Study in Journal of Clinical Oncology Article in Clinical Research News New drug for MS Study in PNAS Guests CEO Marshall Summar, M.D., and CMO Tamanna Roshan Lal, M.D., with Uncommon Cures Article in Clinical Research News The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.…
Tune into this month’s episode of the Scope of Things, where host Deborah Borfitz covers the use of AI for trial screening and recruitment purposes, a diabetes drug that may help treat sleep apnea, questionable advice from the FDA given to departing staffers, why the entire clinical trial enterprise may need to be revamped to eliminate systemic biases, and more. Hannah Kemp, vice president of strategic client engagement at Surgo Health, also joins the conversation to talk about how Surgo Health is helping companies recruit participants and her SCOPE 2024 presentation, as well as her thoughts on patient-focused drug design and the challenge of getting study sponsors on-board with enrollment strategies. SHOW NOTES News Roundup AI for clinical trial screening Study in NEJM AI AI for trial recruitment Study in Ophthalmology Science Drug therapy for sleep apnea Study in NEJM Investigation on departing FDA employees Article in The BMJ N-Power Medicine/Merck collaboration Press release Youth prediabetes/diabetes dataset Link to POND web portal Systemic biases in randomized controlled trials Study in Journal of Ethnicity in Substance Abuse GUEST BIO Hannah Kemp, vice president of strategic client engagement, Surgo Health Hannah Kemp is the Vice President of Strategic Client Engagement at Surgo Health. In her role, she helps clients develop more patient-centric healthcare and clinical trials leveraging Surgo’s novel data. Ms. Kemp has led large-scale projects across multiple therapeutic areas from infectious disease, maternal health, vaccines, and cancer and published. Ms. Kemp brings an ecosystem perspective having worked across healthcare from clinical trials to digital health to payors. Prior to joining Surgo, Ms. Kemp worked with Deloitte consulting as well as directly for the US government. She has a BA from the University of Virginia and an MPA from George Washington University. The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.…
In this month’s episode of the Scope of Things, host Deborah Borfitz gives you the latest news on the fallacy of a survival benefit for cancer patients participating in clinical trials, how and why federally qualified health centers are getting involved in studies, efforts to disrupt the current practice of excluding pregnant and lactating women from participation, great news about the impact of precision medicine on the outcomes of kids suffering from aggressive cancers, and more. Jonathan Kimmelman, PhD, Professor of Biomedical Ethics at McGill University, also joins Deborah to discuss current dilemmas in clinical development and how research standards are trending. Kimmelman talks about the ethical implications when trial sponsors don’t fully disclose how patient input is utilized in drug development, key policies that are necessary and would have a big impact on regulators, and what would-be participants can do to be more informed about trials. SHOW NOTES News Roundup “Participation effect” not a benefit of cancer trials Article in JAMA Article in Annals of Internal Medicine CARE for Health initiative of the NIH Editorial in Science Integration of clinical trials with healthcare delivery Special communication in JAMA FQHCs conducting clinical trials Episode 21 with Javara Medical Director Colleen Purcell Tenan, M.D. Factors influencing trial participation by pregnant and lactating women Review in PLOS Medicine Flicker stimulation for epilepsy Study in Nature Communications Precision medicine for kids with cancer Article in Nature Medicine GUEST BIO Jonathan Kimmelman, PhD, James McGill Professor of Biomedical Ethics, McGill University Jonathan Kimmelman, PhD, is James McGill Professor of Biomedical Ethics at McGill University. His research group, STREAM (Studies in Translation, Ethics and Medicine) uses empirical and theoretical methods to understand the ethical, policy, and scientific dynamics of developing new drugs. Kimmelman received the Maud Menten New Investigator Prize (2006), a CIHR New Investigator Award (2008), a Humboldt Bessel Award (2014), and was elected a Hastings Center Fellow (2018). He has sat on various advisory bodies within the The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.…
In this episode of the Scope of Things, host Deborah Borfitz covers the latest news on an AI model for comparing drug effectiveness, adoption of minimal residual disease as an endpoint for multiple myeloma, using HIV treatments for Alzheimer’s disease, lack of diversity in Alzheimer’s trials, and more. Yvonne Rodriguez, founder and CEO of Egality Sciences, also joins the conversation to talk about breaking down the barriers to clinical research participation in underserved communities. She also delves into her personal story of what inspired her to start her company, how Egality Sciences is teaching physicians and staff at local hospitals to get and stay involved with industry-sponsored studies, and the challenges that need to be overcome to ensure that every patient has equal access to clinical trials as a treatment option. SHOW NOTES News Roundup AI for predicting treatment outcomes Article in Patterns Minimal residual disease as an endpoint FDA information package (multiple myeloma) Window-of-opportunity clinical trials Ontario Institute for Cancer Research webpage HIV treatments for Alzheimer’s? Proof-of-concept study in Pharmaceuticals Implantable device for brain disorders Study published in Science Advances Motif Neurotech website Lack of diversity in Alzheimer’s disease trials Study about differences in plasma biomarker eligibility OMB’s updated race/ethnicity standards PDF of final recommendations GUEST BIO Yvonne Rodriguez, founder and CEO of Egality Sciences Yvonne Rodriguez is the founder and CEO of Egality Sciences. Originally from Socorro, Texas, she started working on clinical trials after receiving her BBA from St. Mary’s University, in San Antonio, Texas. She brings over 20 years of clinical research industry experience having worked at clinical research sites, IRBs, CROs, and pharmaceutical and biomedical device companies. Prior to starting Egality Sciences, Yvonne worked at AstraZeneca and led projects in the DEI space that had successful results. Yvonne holds a Master’s of Science in Health Sciences from George Washington University, and has received a professional certificate from Oxford University. The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.…
![Artwork](/static/images/128pixel.png)
1 Episode: 26 - Digital Twins, Care-For-All European Platform, and the Impact and Future of Wearables and Microsampling 33:37
In this episode of the Scope of Things, host Deborah Borfitz brings you the monthly breakdown on current events, such as tailoring medications to individual patients using digital twins, the use of a skin biopsy test to diagnose neurodegenerative diseases, and the launch of a European-wide platform promoting access to care for all. She also speaks with Michael Snyder, chair of the department of genetics at Stanford University School of Medicine and director of the Center of Genomics and Personalized Medicine at Stanford, about the growing adoption of wearables and home microsampling—and how this will dramatically change clinical trials and care. Snyder also delves into the “Amazon-ing” of healthcare and how he envisions the creation and future of personalized metrics and customized interventions and how they can improve trial outcomes. Show Notes News Roundup Probabilistic approach to diagnosing cancer Story in Clinical Research News Functional precision medicine Pediatric study in Nature Medicine Cancer clinical trial access JAMA Oncology article on new recruitment approach Endpoints in cancer screening trials Comparative study in JAMA Rate of participation in cancer research Study in Journal of Clinical Oncology Tailoring medications with digital twins Article in Genome Medicine Skin biopsy test for neurodegenratve diseases Study in JAMA European Patient Observatory Initiatives encourging innovation GUEST BIO Michael Snyder, Ph.D., chair of the department of genetics at Stanford University School of Medicine and director of the Center of Genomics and Personalized Medicine at Stanford As a pioneer of Precision Medicine, Dr Michael Snyder has invented many technologies enabling the 21st century of healthcare including systems biology, RNA sequencing, and protein chip. Dr Snyder has initiated the Big Data approach to healthcare through his work using omics to detect early stage disease, including wearables to detect infectious diseases like COVID-19, and at-home microsampling to measure hundreds of molecules from a single drop of blood. He is the first researcher to gather petabytes of data on individuals, which is 1 million - 1 trillion times more data than the average clinician collects. He as published over 800 papers and is one of the most cited scientists. In terms of co The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.…
In this month’s episode of the Scope of Things, host Deborah Borfitz covers the latest news and emerging trends, including the launch of a company using single-solution software to connect a global network of clinical trial sites to study sponsors, a pharmacy-first program in the UK, a centralized staffing initiative at the National Cancer Institute, progress in getting patient-derived organoids into clinical trials to evaluate drug response, and more. She also speaks with Lifelines Neuro’s chief scientific officer Dona Murphey, M.D., Ph.D. about shortcomings in the way EEGs are being use in clinical trials to monitor participants with potential brain damage, how EEG monitoring should be used in clinical research, and what the FDA has to say about all of this. Show Notes News Roundup Launch of Pi Health Business Wire news release Pharmacy First initiative in the UK National Health Service announcement Story on Walgreens’ clinical trials business Pediatric rare disease research Article in Hepatology about utility of real-world cohort NCI Virtual Clinical Trials Office Announcement on the NCI website Precision oncology clinical trial landscape Novotech whitepaper Translational Research Innovation Program Announcement by IRB Barcelona Patient-derived organoids in clinical trials Study in Cells Tissues Organs GUEST BIO Dona Murphey, M.D., Ph.D., chief scientific officer for Lifelines Neuro Dona is a neurologist, neuroscientist, historian of science, and community health worker educated at Harvard and Baylor College of Medicine. She currently serves as principal consultant at In Phase Neuro and fractional chief scientific officer at Synthesys Brain Health (a joint endeavor between Lifelines Neuro and Neurovative Diagnostics), specializing in the area of EEG in clinical trials. The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.…
In this month’s episode of the Scope of Things , host Deborah Borfitz catches listeners up with the latest news of the clinical trials and research industry, starting with SCOPE 2024, where a record-breaking 4,000 attendees arrived to learn and discuss about new products, technology, and ideas. Other hot topics in this episode include convergence of clinical research and clinical care, patient centricity, protocol complexity, the growing use of AI, and an update on decentralized clinical trials. She also interviews CliniSpan Health founder and CEO Dezbee McDaniel, winner of the pitch contest at SCOPE, about his company’s novel social media influencer relationship management platform for improving clinical research diversity. LINKS Summit for Clinical Ops Executives (SCOPE) Conference website Convergence of clinical research and clinical care Story in Clinical Research News [ link to come, story runs 2/27? ] Oliver Patch Project Website Conference themes Savvy Cooperative’s #AskPatients website Barnett International’s GCP reference guide ProofPilot integrates Magnol.AI Press release TransCelerate’s Participant Data Return initiative Resource pack Impact of protocol design on trial performance Study in Therapeutic Innovation & Regulatory Science Use of AI in clinical development FDA-issued discussion paper The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.…
![Artwork](/static/images/128pixel.png)
1 Episode: 23 - Discussing Review Boards, Social Media, and World Events With Donna Dorozinsky 28:29
In this episode of The Scope of Things , host Deborah Borfitz provides a rundown of the latest news in the clinical trials field: a massive health research initiative in the UK, widespread overdosing of trial participants, a cholesterol-lowering vaccine, the growing popularity of phage therapy, a novel scoring mechanism for de-risking trials for chronic diseases, a strategy for making staph vaccines a reality, and the latest oral drugs heading to trials that could eliminate one of the chief barriers to insulin therapy for diabetics. Deborah also speaks with Donna Dorozinsky, President & CEO of Just in Time GCP, about recent changes related to expectations of institutional review boards, the use of social media for recruitment and communication purposes, and the impact of world events on clinical data management. News Roundup Our Future Health Program website Medication adherence crisis Story covering the issues and smart packaging solutions PLOS One paper about overdosing of marketed drugs Cholesterol-lowering vaccine Story about the bivalent vaccine and its promise NPJ Vaccines paper covering preclinical study results Phage therapy World Economic Forum report on Top 10 Emerging Technologies of 2023 Cell paper reviewing state-of-the-art in phage therapy Graham Hatfull podcast episode Pharmagenic enrichment score Circulation paper on using genetics to inform interventions Story about how the patient scoring method enables precision medicine Staph vaccine trials Cell Reports Medicine paper on immune imprinting informing vaccine development New oral insulin drug Nature Nanotechnology paper on the formulation with reduced episodes of hypoglycaemia Guest D The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.…
New Year, new podcast format! In 2024’s first episode of the Scope of Things , host Deborah Borfitz gives you the latest news from the clinical trials industry, including AI’s role in the creation of digital twins, the obesity epidemic and the drugs intended to combat it, improving diversity in trial candidates, and more. We also have expert advice from Ward Lemaire, VP Head of Data Management and Central Monitoring at J&J Innovative Medicine, and Dan Hydes, Co-Founder and CEO at IgniteData, on SCOPE’s new Startup Pitch Competiton, and how start-up companies can meet multiple demands and needs, direct their limited resources, and keep the innovation train going. New Advisory Board Ken Getz podcast episode Ramita Tandon podcast episode News Roundup AI and Chatbots Belong.Life Microsoft’s Trial Matcher UF and NVIDIA’s GatorTronGPT Genentech’s smart digital assistants Digital Twins Pan-European project simulating stroke treatments Obesity Clinical Trials JAMA paper on unintended consequences of weight-loss drugs FDA’s Ozempic label change Physicians in Europe preferentially recommend lifestyle changes New areas of interest Trial begins for Insilico Medicine’s latest AI-discovered drug Brain metastases studies in Italy and Spain Drug repurposing study in Australia for type 1 diabetes Anti-aging TAME trial of Metformin to start Pharmacy Research Organization RxE2 Platform for independent community pharmacists launches The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.…
![Artwork](/static/images/128pixel.png)
1 Episode: 21 - Colleen Purcell Tenan on Providing Patients With Clinical Research Care Options 22:49
Can clinical trials be a helpful treatment option for patients? In this episode of The Scope of Things, host Deborah Borfitz speaks with Colleen Purcell Tenan, MD, Medical Director at Javara, about providing clinical research as a care option for patients. Tenan talks about the benefits of receiving clinical research care from one’s own physician, Javara’s process of matching patients with the right healthcare system for clinical trials, and how Javara supports providers who haven’t done sponsor research before. She also shares her thoughts on where decentralized trial components best fit in clinical studies in a post-pandemic world and using remote technologies for convenient medical care and research. Scope of Things Links: Clinical Research News Scope Summit Javara Links: Javara The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.…
Benvenuto su Player FM!
Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.